Systemic, metabolic and endocrine diseases

We suggest that patients with haemostatic derangements associated with systemic, metabolic and endocrine diseases should be managed perioperatively in collaboration with a haematologist. 2C

We suggest individualised preoperative discontinuation of selective serotonin reuptake inhibitor (SSRI) treatment. 2B

We suggest individualised preoperative discontinuation of antiepileptic agents, such as valproic acid, which may increase bleeding. 2C

We do not recommend preoperative discontinuation of gingko biloba extracts. 1B